FDA Approves Once-Daily Jakafi XR for Myelofibrosis, Polycythemia Vera and GVHD

Jakafi XR is a once-daily, film-coated, extended-release formulation of Jakafi®(ruxolitinib) Once-daily Jakafi XR was shown to provide consisten...

May 05, 2026 | Tuesday | News
LTS LOHMANN Therapie-Systeme AG Expands CDMO Portfolio with U.S.-Based Ophthalmic Drug Delivery Services

LTS LOHMANN Therapie-Systeme AG ("LTS"), a leading pharmaceutical technology company specializing in advanced drug delivery systems, announced the expans...

April 01, 2026 | Wednesday | News
Kytopen Corp., T-CURX GmbH, and Fraunhofer Institute for Cell Therapy and Immunology (IZI) Launch Cell Therapy Center of Excellence in Germany

Kytopen partners with T-CURX and the Fraunhofer Institute for Cell Therapy and Immunology (IZI) in Würzburg and Leipzig, Germany to establish a jo...

May 01, 2026 | Friday | News
Taiho Oncology, Inc. Advances First ADC Candidate ARC-02 into Phase 1 Following U.S. Food and Drug Administration IND Clearance

Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that the U.S. Food and Drug Administra...

April 30, 2026 | Thursday | News
PCI Pharma Services Commits Over $1 Billion to Expand Sterile Fill-Finish and Drug-Device Capabilities Across US and Europe

PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on i...

April 29, 2026 | Wednesday | News
Santhera Pharmaceuticals Wins Positive CHMP Opinion to Expand AGAMREE® Use to Younger Duchenne Patients

Santhera Pharmaceuticals (SIX: SANN)  announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA...

April 28, 2026 | Tuesday | News
Novartis Secures EU Approval for Rhapsido® (Remibrutinib), First Oral Targeted Therapy for Chronic Spontaneous Urticaria

Significant improvements as early as Week 1, favorable safety profile and no liver safety concerns in REMIX 1 & 2 studies ...

April 28, 2026 | Tuesday | News
PrecisionBiotics And Biocodex Renew Strategic Partnership To Advance Microbiome Innovation

PrecisionBiotics®, part of Novonesis, and Biocodex have formalised the next phase of their partnership at a strategic leadership meeting with the sig...

April 24, 2026 | Friday | News
Evonik Industries Commits €80M to Expand Biotechnology Capabilities at Slovenská Ľupča Fermas Site

Marks the second major investment at the Slovenská Ľupča site in recent years Follows the group’s strategy to strengthen leading ...

April 23, 2026 | Thursday | News
Merck Launches Bio-Based HPLC Solvent Portfolio to Advance Sustainable Chromatography

Solvents made from renewable feedstocks help reduce reliance on fossil-fuel-based materials Drop-in replacements preserve established chromatography p...

April 23, 2026 | Thursday | News
Oncodesign Services Expands Radionuclide Access Through Extended Collaboration with GIP ARRONAX

Oncodesign Services has extended its collaboration with GIP ARRONAX to secure access to astatine-211 (At-211) as well as other radionuclides used in targ...

April 20, 2026 | Monday | News
Repligen Opens New Training & Innovation Center in the Netherlands to Strengthen Global Bioprocessing Support

Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the grand opening of its new ...

April 20, 2026 | Monday | News
Swissmedic Approves Bavarian Nordic’s VIMKUNYA®, Marking Fourth Global Authorization for Chikungunya Vaccine

Bavarian Nordic A/S announced that the Swiss Agency for Therapeutic Products, Swissmedic, has approved VIMKUNYA® (recombinant, adsorbed) for active i...

April 17, 2026 | Friday | News
Cepheid And Oxford Nanopore Expand Collaboration To Advance Rapid Pathogen Genomic Workflows

Phase two collaboration aims to expand access to streamlined genomic workflows for infectious disease research Cepheid, a Danaher company and a leader i...

April 16, 2026 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close